Diflucan (fluconazole) is primarily classified as a Prescription Only Medicine (POM) in the UK for systemic antifungal therapy. However, specific low-dose topical or vaginal fluconazole products have been reclassified as Pharmacy Medicines (P) and may be supplied without a prescription following a clinical assessment by a pharmacist. The only over‐the‐counter options are usually single-dose 150 mg vaginal capsules for treating thrush in women. Systemic oral fluconazole capsules (50 mg, 100 mg, 150 mg, 200 mg) remain POM and require a prescription issued by a qualified healthcare professional.
In the UK, human medicines are classified into three main categories: Prescription Only Medicines (POM), Pharmacy Medicines (P) and General Sales List (GSL) medicines. A Pharmacy Medicine may be supplied without a doctor’s prescription but only by or under the supervision of a registered pharmacist, ensuring appropriate advice and screening for safety. “Over the counter” in many other countries might mean off-the-shelf retail, but in the UK, a P classification still requires pharmacy control.
Fluconazole is a triazole class antifungal medication used to treat a broad range of fungal infections. It acts by inhibiting fungal cytochrome P450 enzymes that are critical for ergosterol synthesis—a key sterol component of fungal cell membranes. Without ergosterol, fungal cell walls become compromised, leading to cell death or growth arrest.
Introduced in the late 1980s, fluconazole quickly became popular due to its favourable safety profile, oral bioavailability, and ability to penetrate body fluids including cerebrospinal fluid. Its use expanded from systemic candidiasis to vaginal and mucocutaneous fungal infections, as well as prophylaxis in immunocompromised populations.
Generic fluconazole contains the same active ingredient at the same therapeutic dosage as the branded reference product (Diflucan®) and must meet stringent regulatory standards. This makes purchase cheaper and accessible online or in pharmacy stores, often without prescription for specific vaginal formulations.
Generic and branded fluconazole capsules, tablets, and suspension formulations may differ in excipients, appearance, and packaging, but the active pharmaceutical ingredient (API) fluconazole remains consistent. The variety offers options for patients with allergies or sensitivities to certain inactive ingredients.
Fluconazole selectively inhibits fungal lanosterol 14α-demethylase (a cytochrome P450 enzyme). This enzyme catalyses the conversion of lanosterol to ergosterol, an essential component of fungal cell membranes. Inhibition leads to depletion of ergosterol and accumulation of toxic methylated sterols, disrupting membrane integrity and causing fungal cell death or arrest.
Fluconazole is rapidly and almost completely absorbed after oral administration, with bioavailability exceeding 90%. Peak plasma concentrations occur within 1–2 hours. Food does not significantly affect absorption, making dosing flexible in relation to meals.
Fluconazole distributes widely into tissues and fluids, including skin, nails, sputum, and cerebrospinal fluid, achieving therapeutic concentrations. It is minimally metabolised by the liver and primarily excreted unchanged via the kidneys, with a mean plasma half-life of approximately 30 hours, enabling once‐daily dosing in most indications.
Renal excretion is the major pathway; dosage adjustment is recommended in patients with moderate to severe renal impairment to avoid accumulation and toxicity.
Prices for generic fluconazole vary by strength and pack size, retailer, and whether purchased online or in-store. Vaginal single-dose 150 mg capsules supplied as a Pharmacy Medicine are typically priced between £3 and £8 per capsule. Prescription systemic doses (50 mg–200 mg) depend on pharmacy dispensing fees, prescription charges, or NHS coverage.
Online pharmacies operating in the UK may offer cheaper generic fluconazole due to lower overheads, bulk purchasing, and competitive pricing models. Nevertheless, consumers should ensure they order from a registered, MHRA→compliant pharmacy to guarantee quality and authenticity.
| Example | Strength | Formulation | Price | Status | Note |
|---|---|---|---|---|---|
| Generic A | 150 mg | Vaginal capsule | £4.50 per capsule | Pharmacy medicine | Single-dose, purchase without prescription |
| Generic B | 100 mg | Oral capsule | £5.20 per 10-pack | Prescription Only | Requires valid prescription |
Fluconazole is available in oral capsule strengths of 50 mg, 100 mg, 150 mg and 200 mg. A single-dose 150 mg vaginal capsule is authorised as a Pharmacy Medicine for uncomplicated vulvovaginal candidiasis. Oral suspension (2 mg/mL or 10 mg/mL) is available by prescription for paediatric and geriatric use.
Solid oral formulations: hard gelatin capsules and tablets; liquid suspension for those unable to swallow capsules; single-dose vaginal capsules for self-treatment of thrush; injectable solution for systemic fungal infections in hospital settings (POM only).
Pack sizes reflect approved non‐prescription supply: single-dose packs for thrush (150 mg vaginal capsule). Prescription pack sizes vary (e.g., 10, 20 or 28 capsules) tailored to treatment course duration.
| Feature | Why it matters |
| Active ingredient | Fluconazole, ergosterol synthesis inhibitor |
| Strength | Dose correlates to severity and type of infection |
| Formulation | Oral vs vaginal vs injectable |
| Pack size | Affects supply category (POM vs P) |
| Legal category | Determines pharmacy controls and need for prescription |
Generic fluconazole capsules and tablets are bioequivalent to branded references when approved, often at a cheaper price. Appearance and excipients may differ, but clinical efficacy is maintained.
Single‐dose 150 mg vaginal capsule indicated for acute vulvovaginal candidiasis in women with typical symptoms of itching, discharge and irritation. A Pharmacy Medicine allows self‐care purchase without prescription after pharmacist consultation.
Oral thrush, predominantly in infants, denture wearers, and immunocompromised patients. Treatment typically requires multi‐day courses of oral suspension or capsules under POM status.
Serious invasive infections treated with high‐dose oral or intravenous fluconazole under specialist supervision (POM). Hospital use includes cryptococcal meningitis prophylaxis in HIV patients.
Off‐label use for cutaneous candidiasis, such as intertrigo or balanitis; often topical azoles or oral terbinafine are preferred.
Nail infections treated with longer systemic courses (6–12 months) of fluconazole or terbinafine. Requires prescription and monitoring for hepatic side effects.
Most oral fluconazole strengths (50, 100, 150, 200 mg) and formulations beyond single-dose vaginal capsule require a valid prescription from a qualified prescriber.
Vaginal fluconazole 150 mg single-dose capsules are P, available only through a pharmacist after a consultation to confirm diagnosis and assess for contraindications.
No fluconazole product is classified GSL; antifungal creams and pessaries for vaginal thrush from other azole classes may be GSL, but fluconazole P formulations remain pharmacy controlled.
The Medicines and Healthcare products Regulatory Agency (MHRA) assesses applications for reclassification, manufacturer submissions, pack size changes, and enforces compliance with supply regulations.
Terbinafine tablets and topical creams for dermatophyte infections—commonly POM for systemic use, GSL or P for topical.
Flucytosine combined with amphotericin B for invasive fungal infections under hospital care (POM).
Fluconazole has higher water solubility and penetrates CSF; itraconazole may have broader dermatophyte coverage but variable oral absorption.
Terbinafine concentrates in skin and nails, effective against dermatophytes; fluconazole more suited for candida and systemic infections.
| Feature | Fluconazole | Itraconazole | Terbinafine |
| Drug class | Triazole antifungal | Triazole antifungal | Allylamine antifungal |
| Main mechanism | Ergosterol synthesis inhibition | Ergosterol synthesis inhibition | Squalene epoxidase inhibition |
| OTC availability | 150 mg vaginal P only | None | Topical GSL/P |
| Prescription uses | Yes | Yes | Yes (oral) |
High-sugar diets may promote candida overgrowth. Limiting refined carbohydrates, incorporating probiotics and maintaining hydration can support antifungal therapy.
Fluconazole may inhibit metabolism of alcohol; heavy drinking increases risk of liver toxicity. Patients should limit alcohol consumption during treatment.
Smoking can impair mucosal immunity, increasing susceptibility to candida infections. Smoking cessation may enhance treatment outcomes.
Maintaining dry skin folds, breathable underwear, and good genital hygiene can reduce recurrence risk for genital thrush.
Headache, nausea, abdominal discomfort, diarrhoea, transient skin rash. Typically mild and reversible on discontinuation.
| System | Examples |
| Gastrointestinal | Nausea, abdominal pain, diarrhoea |
| Nervous system | Headache, dizziness |
| Skin | Rash, pruritus |
| Hepatic | Elevated liver enzymes (rare) |
| Hypersensitivity | Serious allergic reactions (very rare) |
Although rare, anaphylaxis, angioedema or Stevens-Johnson syndrome can occur. Immediate medical attention is required if severe reaction develops.
Single-dose vaginal use is safe for uncomplicated cases. Systemic therapy beyond 14 days warrants monitoring of liver function and renal clearance.
Prolonged antifungal therapy may require regular liver enzyme checks. Discontinue if significant hepatotoxicity arises.
Repeated courses can select for resistant candida strains. Recurrent infections may require culture and sensitivity testing to guide alternative therapy.
Use with caution in patients with pre-existing hepatic impairment. Dose adjustment and close monitoring essential.
Single-dose vaginal use may be considered in pregnancy after risk–benefit assessment. Oral systemic fluconazole is contraindicated in pregnancy due to teratogenic risk. Small amounts excreted in breast milk; consultation advised.
Fever, severe abdominal pain, jaundice or persistent vomiting require immediate medical evaluation rather than self-treatment.
A generic medicine has the same active ingredient, dosage form, strength and route of administration as the reference medicine. It meets equivalent standards of quality, safety and efficacy, offering a cheaper option to purchase without prescription when classified P.
Different manufacturers may use varying excipients, pack sizes and legal categories, leading to distinct patient information leaflets even for the same active dose of fluconazole.
Consulting a pharmacist ensures correct diagnosis of thrush, screening for contraindications, and guidance on proper usage, adherence and recognising red-flag symptoms requiring referral.
MHRA website, electronic Medicines Compendium, NICE guidelines, and professional pharmacy bodies provide up-to-date information. Always verify product-specific details before purchase or use.
No. This content is for general information by Markeaton Pharmacy, 126 Kedleston Road, Derby, DE22 1FX. Speak to our pharmacy team for tailored advice before ordering or purchasing Diflucan.